4.20
price down icon0.94%   -0.04
after-market After Hours: 4.21 0.010 +0.24%
loading
Sight Sciences Inc stock is traded at $4.20, with a volume of 153.09K. It is down -0.94% in the last 24 hours and up +43.34% over the past month. Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
See More
Previous Close:
$4.24
Open:
$4.24
24h Volume:
153.09K
Relative Volume:
0.71
Market Cap:
$217.14M
Revenue:
$81.06M
Net Income/Loss:
$-55.55M
P/E Ratio:
-3.6842
EPS:
-1.14
Net Cash Flow:
$-47.98M
1W Performance:
+19.32%
1M Performance:
+43.34%
6M Performance:
+13.51%
1Y Performance:
-41.26%
1-Day Range:
Value
$4.185
$4.30
1-Week Range:
Value
$3.3607
$4.30
52-Week Range:
Value
$2.03
$8.45

Sight Sciences Inc Stock (SGHT) Company Profile

Name
Name
Sight Sciences Inc
Name
Phone
(415) 889-0550
Name
Address
4040 CAMPBELL AVE,, MENLO PARK
Name
Employee
216
Name
Twitter
Name
Next Earnings Date
2025-03-05
Name
Latest SEC Filings
Name
SGHT's Discussions on Twitter

Compare SGHT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
SGHT
Sight Sciences Inc
4.20 181.99M 81.06M -55.55M -47.98M -1.14
Medical Devices icon
ABT
Abbott Laboratories
133.94 231.14B 42.34B 13.50B 6.66B 7.71
Medical Devices icon
BSX
Boston Scientific Corp
102.83 154.60B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
383.10 146.12B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
87.00 105.64B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
77.77 45.60B 5.54B 4.18B 623.10M 7.00

Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-06-24 Initiated UBS Buy
Nov-04-24 Downgrade Lake Street Buy → Hold
Aug-21-24 Initiated Lake Street Buy
Sep-12-23 Downgrade BofA Securities Neutral → Underperform
Sep-12-23 Downgrade Piper Sandler Overweight → Neutral
Sep-12-23 Downgrade William Blair Outperform → Mkt Perform
Aug-24-23 Downgrade Morgan Stanley Overweight → Equal-Weight
Jul-10-23 Downgrade Citigroup Buy → Neutral
Jan-06-23 Upgrade Stifel Hold → Buy
Oct-04-22 Initiated Needham Hold
Jul-26-22 Initiated Stifel Hold
Feb-03-22 Initiated William Blair Outperform
Jan-07-22 Upgrade Morgan Stanley Equal-Weight → Overweight
View All

Sight Sciences Inc Stock (SGHT) Latest News

pulisher
Jun 05, 2025

sight sciences appoints new board member and holds annual meeting By Investing.com - Investing.com India

Jun 05, 2025
pulisher
Jun 05, 2025

Sight Sciences Holds Annual Stockholders Meeting - TipRanks

Jun 05, 2025
pulisher
Jun 05, 2025

sight sciences appoints new board member and holds annual meeting - Investing.com

Jun 05, 2025
pulisher
Jun 05, 2025

ProShare Advisors LLC Makes New $36,000 Investment in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World

Jun 05, 2025
pulisher
Jun 03, 2025

Sight sciences director Encrantz buys $376,429 in stock By Investing.com - Investing.com Nigeria

Jun 03, 2025
pulisher
Jun 03, 2025

Sight sciences director Encrantz buys $376,429 in stock - Investing.com

Jun 03, 2025
pulisher
Jun 01, 2025

Sight Sciences Independent Chairman Acquires 7.8% More Stock - simplywall.st

Jun 01, 2025
pulisher
May 30, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Receives Consensus Rating of “Hold” from Analysts - Defense World

May 30, 2025
pulisher
May 30, 2025

Sight sciences director Staffan Encrantz buys $451k in stock By Investing.com - Investing.com South Africa

May 30, 2025
pulisher
May 29, 2025

Sight sciences director Staffan Encrantz buys $451k in stock - Investing.com

May 29, 2025
pulisher
May 29, 2025

BNP Paribas Financial Markets Invests $262,000 in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World

May 29, 2025
pulisher
May 29, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Shares Sold by Bank of America Corp DE - Defense World

May 29, 2025
pulisher
May 29, 2025

Northern Trust Corp Has $1.21 Million Stock Holdings in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World

May 29, 2025
pulisher
May 27, 2025

Sight Sciences at Stifel Forum: Strategic Growth Amid Challenges By Investing.com - Investing.com Canada

May 27, 2025
pulisher
May 23, 2025

Sight Sciences price target raised to $3.60 from $3.20 at Citi - TipRanks

May 23, 2025
pulisher
May 23, 2025

D. E. Shaw & Co. Inc. Acquires 88,738 Shares of Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World

May 23, 2025
pulisher
May 23, 2025

Sight Sciences (SGHT) Receives Increased Price Target from Citigroup | SGHT Stock News - GuruFocus

May 23, 2025
pulisher
May 22, 2025

Sight Sciences (SGHT) Receives Increased Price Target from Citig - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Sight Sciences (SGHT) Target Price Raised by Citi | SGHT Stock News - GuruFocus

May 22, 2025
pulisher
May 16, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Shares Purchased by Dimensional Fund Advisors LP - Defense World

May 16, 2025
pulisher
May 15, 2025

Nautilus Biotechnology And 2 Other Penny Stocks With Promising Potential - simplywall.st

May 15, 2025
pulisher
May 14, 2025

Sight Sciences to Present at the Stifel 2025 Virtual Ophthalmology Forum on May 27th - The Manila Times

May 14, 2025
pulisher
May 14, 2025

Sight Sciences Reveals New Ophthalmology Tech Updates at Exclusive Stifel 2025 ForumLive Webcast Available - Stock Titan

May 14, 2025
pulisher
May 14, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Surges 44% Yet Its Low P/S Is No Reason For Excitement - simplywall.st

May 14, 2025
pulisher
May 14, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Shares Acquired by Wells Fargo & Company MN - Defense World

May 14, 2025
pulisher
May 13, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Shares Purchased by Barclays PLC - Defense World

May 13, 2025
pulisher
May 12, 2025

Sight Sciences (NASDAQ:SGHT) Price Target Raised to $3.00 - Defense World

May 12, 2025
pulisher
May 11, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Q1 2025 Earnings Call Transcript - MSN

May 11, 2025
pulisher
May 10, 2025

Analysts Have Conflicting Sentiments on These Healthcare Companies: Evolent Health (EVH), Verastem (VSTM) and Sight Sciences (SGHT) - The Globe and Mail

May 10, 2025
pulisher
May 10, 2025

Sight Sciences (SGHT) Price Target Raised Amid Growth Potential - GuruFocus

May 10, 2025
pulisher
May 09, 2025

Sight Sciences (SGHT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN

May 09, 2025
pulisher
May 09, 2025

Sight Sciences, Inc. Earnings Call: Mixed Results and Strategic Focus - TipRanks

May 09, 2025
pulisher
May 09, 2025

Earnings call transcript: Sight Sciences misses Q1 2025 EPS forecast, stock rises - Investing.com Nigeria

May 09, 2025
pulisher
May 09, 2025

Sight Sciences stock holds as Needham reiterates rating By Investing.com - Investing.com Nigeria

May 09, 2025
pulisher
May 09, 2025

Sight Sciences stock holds as Needham reiterates rating - Investing.com

May 09, 2025
pulisher
May 09, 2025

Sight Sciences: Balancing Resilience and Caution Amid Tariff Challenges - TipRanks

May 09, 2025
pulisher
May 09, 2025

Sight Sciences (SGHT): Analyst Raises Price Target Despite Hold Rating | SGHT Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Sight Sciences Inc (SGHT) Q1 2025 Earnings Call Highlights: Navigating Market Challenges and ... By GuruFocus - Investing.com Canada

May 09, 2025
pulisher
May 09, 2025

Sight Sciences Reports Q1 2025 Earnings and Outlook - TipRanks

May 09, 2025
pulisher
May 09, 2025

Sight Sciences Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Revenue Guidance - GlobeNewswire

May 09, 2025
pulisher
May 08, 2025

Sight Sciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 08, 2025
pulisher
May 08, 2025

Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

SGHT Updates 2025 Financial Guidance Amidst Medicare Changes | SGHT Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Sight Sciences reports Q1 EPS (28c) , consensus (23c) - TipRanks

May 08, 2025
pulisher
May 08, 2025

Sight Sciences Reports Q1 2025 Financial Results - TipRanks

May 08, 2025
pulisher
May 07, 2025

Selling Sight Sciences Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders - simplywall.st

May 07, 2025
pulisher
May 07, 2025

Marshall Wace LLP Takes Position in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World

May 07, 2025
pulisher
May 05, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Receives Average Recommendation of “Hold” from Analysts - Defense World

May 05, 2025
pulisher
May 02, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Shares Bought by JPMorgan Chase & Co. - Defense World

May 02, 2025

Sight Sciences Inc Stock (SGHT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Sight Sciences Inc Stock (SGHT) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Encrantz Staffan
Director
Jun 02 '25
Buy
3.88
30,799
119,439
1,231,257
Encrantz Staffan
Director
Jun 03 '25
Buy
3.97
25,230
100,087
1,256,487
Encrantz Staffan
Director
May 29 '25
Buy
3.59
60,128
215,739
1,157,705
Encrantz Staffan
Director
May 27 '25
Buy
3.44
41,346
142,065
1,070,862
Encrantz Staffan
Director
May 28 '25
Buy
3.52
26,715
93,930
1,097,577
Bauerlein Alison
Chief Financial Officer
May 19 '25
Sale
3.48
13,066
45,430
636,728
$317.16
price down icon 0.64%
medical_devices STE
$243.58
price up icon 0.61%
medical_devices SNN
$30.30
price up icon 3.52%
$71.55
price up icon 0.59%
$85.74
price up icon 0.15%
medical_devices EW
$77.77
price down icon 0.10%
Cap:     |  Volume (24h):